IMUX - IMMUNIC, INC.
0.9853
-0.085 -8.596%
Share volume: 1,110,738
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$1.07
-0.08
-0.08%
View ratios
Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
---|---|---|---|---|
Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | |
Report Date | 05-08-2024 | 08-08-2024 | 11-07-2024 | |
Total revenue | 0.000 | 0.000 | 0.000 | |
Cost of revenue | 0.000 | 0.000 | 0.000 | |
Gross profit | 0.000 | 0.000 | 0.000 | |
nan% | nan% | |||
Operating expenses | 23.881 M | 22.814 M | 25.726 M | |
Selling general and admin | 5.145 M | 4.491 M | 4.356 M | |
Research and development | 18.736 M | 18.323 M | 21.370 M | |
Total expenses | 23.881 M | 22.814 M | 25.726 M | |
-4.47% | 12.76% | |||
Operating income | -23.881 M | -22.814 M | -25.726 M | |
Ebit | -30.771 M | -22.378 M | -25.144 M | |
Pretax income | -29.584 M | -21.380 M | -24.368 M | |
-27.73% | 13.98% | |||
Income tax | 0.000 | 0.000 | 0.000 | |
Net income basic | 0.000 | 0.000 | 0.000 | |
Net income | -29.584 M | -21.380 M | -24.368 M | |
27.73% | -13.98% |